NCT05433181: A trial that was reported late by University of Pennsylvania
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT05433181 |
|---|---|
| Title | A Phase 1/2, Randomized Double-blind Placebo-Controlled Trial to Test the Safety and Antiviral Activity of ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19) |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 28, 2025 |
| Completion date | April 1, 2025 |
| Required reporting date | April 1, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 1, 2025 |
| Days late | None |